Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas.
D Bradley WellingKatharine A CollierSarah S BurnsJanet L OblingerEdina ShuBeth A Miles-MarkleyCraig C HofmeisterMina S MakaryH Wayne SloneJaishri O BlakeleyS Alireza MansouriBrian A NeffRobert K JacklerAmir MortazaviLong-Sheng ChangPublished in: Laryngoscope investigative otolaryngology (2021)
1b, 4.
Keyphrases